MDA/ALS Newsmagazine Vol. 14, No. 2

February 2009

Cover Story

Some studies suggest that motor neurons, even when healthy, can be killed by toxic neighbors. If so, converting these “sharks” to “dolphins” might slow the pace of ALS. Since the earliest descriptions of ALS, it’s been noted that progressive muscle atrophy (shrinkage) and weakness are hallmarks of...

Features

ALS drug-discovery research is proceeding on many fronts at the ALS Therapy Development Institute (ALS TDI), an MDA-supported laboratory in Cambridge, Mass., whose mission is to rapidly develop therapeutics for ALS. ALS TDI scientists updated the ALS community on their efforts during a Web-ba...
MDA has begun a new research initiative in 2009: MDA Venture Philanthropy (MVP). Designed to bridge a crucial funding gap in the drug development process, MVP will focus on the discovery and clinical application of treatments and cures for neuromuscular diseases, including ALS. MVP evolved from, and...
Although single-switch scanning is considered a slow method for computer access, David Jayne is scanning faster and more accurately with the Impulse switch, which responds to slight muscle movements in his forehead. In the January issue, we explored the technological wonder of a head mouse,...
Scheduling, attending and making the most of follow-up visits at your MDA clinic can make the difference between living with ALS and giving in to it. But oftentimes, people aren’t sure exactly what to expect out of follow-up visits. It’s a mistake, doctors say, to assume that the only purpose of the...

Research Roundup

Advertisements

myMuscleTeam